1 MARKET INTRODUCTION 1.1 Market Definitions 1.2 Objective of the Study 1.3 Limitation 1.4 Stake Holders 1.5 Currency Used in Report 1.6 Scope of the Global Next-generation Sequencing Market Study 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1 Research Methodology for the Global Next-generation Sequencing Market 2.1.1 Main Objective of the Global Next-generation Sequencing Market 3 MARKET SYNOPSIS 4 EXECUTIVE SUMMARY 5 COVID-19 IMPACT 6 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE 7 MARKET INSIGHTS BY PRODUCT/SERVICES 7.1 Consumables 7.2 Platforms 7.3 Services 7.4 Bioinformatics 8 MARKET INSIGHTS BY TECHNOLOGY 8.1 SBS 8.2 SMRT 8.3 Pyrosequencing 8.4 Ion Semiconductor Sequencing 8.5 Nanopore Sequencing 8.6 Others 9 MARKET INSIGHTS BY APPLICATION 9.1 Biomarkers & Cancer 9.2 Diagnostics 9.3 Drug Discovery 9.4 Personalized Medicine 9.5 Agriculture & Animal Research 9.6 Others 10 MARKET INSIGHTS BY END-USERS 10.1 Pharma Companies 10.2 Biotechnology Companies 10.3 Academic & Government Research Institutes 10.4 Clinical Research 10.5 Others 11 MARKET INSIGHTS BY REGION 11.1 NORTH AMERICA NEXT-GENERATION SEQUENCING MARKET 11.1.1 United States 11.1.2 Canada 11.1.3 Rest of North America 11.2 EUROPE NEXT-GENERATION SEQUENCING MARKET 11.2.1 Germany 11.2.2 France 11.2.3 United Kingdom 11.2.4 Spain 11.2.5 Italy 11.2.6 Rest of Europe 11.3 ASIA PACIFIC NEXT-GENERATION SEQUENCING MARKET 11.3.1 China 11.3.2 Japan 11.3.3 India 11.3.4 Australia 11.3.5 Rest of Asia Pacific 11.4 REST OF THE WORLD NEXT-GENERATION SEQUENCING MARKET 12 NEXT-GENERATION SEQUENCING MARKET DYNAMICS 12.1 Market Drivers 12.2 Market Challenges 12.3 Impact Analysis 13 NEXT-GENERATION SEQUENCING MARKET OPPORTUNITIES 14 NEXT-GENERATION SEQUENCING MARKET TRENDS & INSIGHTS 15 LEGAL & REGULATORY FRAMEWORK 16 DEMAND AND SUPPLY SIDE ANALYSIS 16.1 Demand Side Analysis 16.2 Supply Side Analysis 16.2.1 Top Product Launches 16.2.2 Top Business Partnerships 16.2.3 Top Merger & Acquisitions 17 VALUE CHAIN ANALYSIS 18 COMPETITIVE SCENARIO 18.1 Porter’s Five forces analysis 18.1.1 Bargaining power of Supplier 18.1.2 Bargaining power of Buyer 18.1.3 Industry Rivalry 18.1.4 Availability of Substitute 18.1.5 Threat of new Entrants 19 COMPANY PROFILED 19.1 Bio-rad Laboratories 19.1.1 Key Facts 19.1.2 Business Description 19.1.3 Key Product/Services Offerings 19.1.4 Growth Strategy 19.1.5 SWOT Analysis 19.1.6 Key Financials 19.1.6.1 Revenue Split 19.1.6.2 Financial Overview of Bio-rad Laboratories 19.1.7 Recent Developments 19.1.7.1 Product Launch 19.1.7.2 Partnerships 19.1.7.3 Business Expansion and Investments 19.1.7.4 Merger and Acquisition 19.2 Agilent Technologies 19.3 Illumina, Inc. 19.4 Thermo Fisher Scientific 19.5 F. Hoffmann-La Roche 19.6 Oxford Nanopore Technologies 19.7 Qiagen 19.8 BGI 19.9 PerkinElmer 19.10 Eurofins Scientific 20 DISCLAIMER

Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, BGI, Oxford Nanopore Technologies, PerkinElmer, and Eurofins Scientific